Results for &quot;&quot;N,N-Dimethyltryptamine&quot;&quot;[mesh_terms]

Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.

Taeho Greg Rhee, Pasha A Davoudian, Gerard Sanacora, Samuel T Wilkinson

Drug discovery today 2023;28(12):103818

Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.

Ayse Ceren Kaypak, Amir Raz

Transcultural psychiatry 2022;59(5):665-674

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.

Nicole Galvão-Coelho, Fernanda Palhano-Fontes, Draulio B Araujo, Emerson Arcoverde, José Victor Costa-Macedo, Raynara Bolcont, Érica J Pantrigo, Raissa Almeida, Aline Assunção, Natan Silva-Costa, Sam Tullman, Flávia Arichelle, Sophie Laborde, Handersson Barros, Lucas O Maia, Sérgio Ruschi B Silva, Isabel Wießner, Marcelo Falchi-Carvalho

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2024;80():27-35

Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.

Emil Deleuran Poulsen, Sidse Arnfred, Oliver Rumle Hovmand

Journal of psychopharmacology (Oxford, England) 2024;38(1):19-32

Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.

Henry Lowe, Ngeh Toyang, Blair Steele, Justin Grant, Amza Ali, Lorenzo Gordon, Wilfred Ngwa

Molecules (Basel, Switzerland) 2022;27(8):2520

Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.

Stanley Wong, M Ishrat Husain, Daniel M Blumberger, Joshua D Rosenblat, Brett D M Jones, Aryan Pasricha, Ofer Finkelstein, Nicholas Fabiano, An Yi Yu, Benoit H Mulsant

Journal of psychoactive drugs 2024;56(4):513-529

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.

Rachel Yehuda, George Danias, Charles Saylor, Morgan T Morrison, Hunter Carney, Charlotte Pierce, Carolyn MacLeod, Philip A Bonanno, Josimar Hernandez Antonio, Robert Barsic, Tamar Glatman Zaretsky, Lauren Lepow, Kathleen M Jagodnik

Current neuropharmacology 2024;22(4):636-735

Psychedelics for treatment resistant depression: are they game changers?

Michail Kalfas, Rosie H Taylor, Dimosthenis Tsapekos, Allan H Young

Expert opinion on pharmacotherapy 2024;24(18):2117-2132

Immunological effects of ayahuasca in humans.

Rafael Guimarães dos Santos

Journal of psychoactive drugs 2015;46(5):383-8

Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges.

Dennis J McKenna

Pharmacology & therapeutics 2004;102(2):111-29

Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.

E Gouzoulis-Mayfrank, K Heekeren, A Neukirch, M Stoll, C Stock, M Obradovic, K-A Kovar

Pharmacopsychiatry 2006;38(6):301-11